PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Stopped early · Phase 3 · Has a placebo group

Conditions studied: COVID-19

In brief

This study looks at the safety and effectiveness of PF-07304814 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either PF-07304814 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H6.

Key facts

Study ID
NCT05780541
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
58
Starts
2021-09-15
Expected to finish
2023-07-14
Last updated by the study team
2024-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.